HongShan
Hong Kong, Hong Kong SARhongshan.com
Overview
HongShan is a venture capital and private equity firm that invests globally across the technology, healthcare, and consumer sectors at stages ranging from seed to growth.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Excalipoint Therapeutics | Mar 2026 | Seed | Lead |
| Dify | Mar 2026 | Early Funding | Lead |
| KAST | Mar 2026 | Series A | Co-investor |
| Spirit AI | Feb 2026 | Early Funding | Co-investor |
| QuantX Biosciences | Feb 2026 | Series B | Co-investor |
Key People
Luca Schmid
Managing Director
Tony Xiang
Member Board Of Directors
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.